Literature DB >> 7652463

Serum cytokines in patients with rheumatoid arthritis. Correlation of interferon gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells.

S Sakito1, Y Ueki, K Eguchi, Y Kawabe, S Nagataki.   

Abstract

Serum cytokines such as interleukin 1 beta (IL-1 beta), interferon gamma (IFN-gamma), and tumor necrosis factor alpha (TNF alpha) were measured in 40 patients with rheumatoid arthritis (RA). In the 40 patients studied, serum IL-1 beta was detected in 5 patients, IFN-gamma in 10 patients, and TNF alpha in 20 patients. The IL-1 beta-positive group showed increased values of activity indices compared to the IL-1 beta-negative group. Values of serum IFN-gamma correlated well with the number of peripheral blood lymphocytes and CD3+ cells and with the percentage of CD3+ CD26+ cells. Values of serum TNF alpha correlated positively with the number of peripheral blood monocytes and the percentage of CD3+ HLA-DR+ and CD3+ CD25+ cells. These results indicated that serum IL-1 beta in RA patients reflects the activity of RA, while the serum IFN-gamma and TNF alpha in RA patients may be related to circulating activated lymphocytes and monocytes, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7652463     DOI: 10.1007/bf00286766

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors:  J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

Review 3.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

4.  Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Authors:  C Tetta; G Camussi; V Modena; C Di Vittorio; C Baglioni
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

5.  Increment of Tal positive cells in peripheral blood from patients with rheumatoid arthritis.

Authors:  H Nakao; K Eguchi; A Kawakami; K Migita; T Otsubo; Y Ueki; C Shimomura; H Tezuka; M Matsunaga; K Maeda
Journal:  J Rheumatol       Date:  1989-07       Impact factor: 4.666

6.  Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity.

Authors:  G T Espersen; M Vestergaard; E Ernst; N Grunnet
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

7.  Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

8.  2 dimensional flow cytometric analysis of activation antigens expressed on the synovial fluid T cells in rheumatoid arthritis.

Authors:  M Goto; T Miyamoto; K Nishioka
Journal:  J Rheumatol       Date:  1987-04       Impact factor: 4.666

Review 9.  The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases.

Authors:  D Aderka; H Engelmann; A J Wysenbeek; Y Levo
Journal:  Isr J Med Sci       Date:  1992-02

10.  Production of human tumor necrosis factor from whole blood ex vivo.

Authors:  C E Desch; N L Kovach; W Present; C Broyles; J M Harlan
Journal:  Lymphokine Res       Date:  1989
View more
  5 in total

Review 1.  Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.

Authors:  Yahui Grace Chiu; Christopher T Ritchlin
Journal:  Expert Opin Biol Ther       Date:  2016-11-30       Impact factor: 4.388

2.  Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.

Authors:  P De Paoli; S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; R Talamini; M Comar; M Giacca; U Tirelli
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

3.  Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques (Macaca fascicularis).

Authors:  Eun Wha Choi; Sungjoo Kim
Journal:  Comp Med       Date:  2019-05-08       Impact factor: 0.982

4.  Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis.

Authors:  I Ertenli; I C Haznedaroğlu; S Kiraz; I Celik; M Calgüneri; S Kirazhi
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

5.  Positive and negative cooperativity of TNF and Interferon-γ in regulating synovial fibroblast function and B cell survival in fibroblast/B cell co-cultures.

Authors:  Torsten Lowin; Tareq M Anssar; Marina Bäuml; Tim Classen; Matthias Schneider; Georg Pongratz
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.